SPONSOR
Hangzhou GluBio Pharmaceutical Co., Ltd.
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Polycythemia VeraEssential ThrombocythemiaMyelofibrosisMyelodysplastic SyndromesAcute Myeloid LeukemiaMyeloid Malignancy
Hangzhou GluBio Pharmaceutical Co., Ltd. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myelodysplastic Syndromes.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hangzhou GluBio Pharmaceutical Co., Ltd.
How many clinical trials has Hangzhou GluBio Pharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Hangzhou GluBio Pharmaceutical Co., Ltd., of which 1 are actively recruiting participants. These trials cover conditions including Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hangzhou GluBio Pharmaceutical Co., Ltd. research focus on?
Hangzhou GluBio Pharmaceutical Co., Ltd. clinical trials span Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myelodysplastic Syndromes, Acute Myeloid Leukemia, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hangzhou GluBio Pharmaceutical Co., Ltd. clinical trial?
To participate in a Hangzhou GluBio Pharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hangzhou GluBio Pharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Hangzhou GluBio Pharmaceutical Co., Ltd.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology